AAAAAA
Results: 1-25/29
Authors:
Lesser, G
Kandiah, K
Libow, LS
Likourezos, A
Breuer, B
Marin, D
Mohs, R
Haroutunian, V
Neufeld, R
Citation: G. Lesser et al., Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease, DEMENT G C, 12(2), 2001, pp. 138-145
Authors:
Smith, RE
Haroutunian, V
Davis, KL
Meador-Woodruff, JH
Citation: Re. Smith et al., Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia, NEUROREPORT, 12(13), 2001, pp. 2885-2887
Authors:
Brown, AM
Sheu, RKF
Mohs, R
Haroutunian, V
Blass, JP
Citation: Am. Brown et al., Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (antDNA), J MOL NEURO, 16(1), 2001, pp. 41-48
Authors:
Meador-Woodruff, JH
Davis, KL
Haroutunian, V
Citation: Jh. Meador-woodruff et al., Abnormal kainate receptor expression in prefrontal cortex in schizophrenia, NEUROPSYCH, 24(5), 2001, pp. 545-552
Authors:
Ho, L
Guo, YJ
Spielman, L
Petrescu, O
Haroutunian, V
Purohit, D
Czernik, A
Yemul, S
Aisen, PS
Mohs, R
Pasinetti, GM
Citation: L. Ho et al., Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarraytechnique, NEUROSCI L, 298(3), 2001, pp. 191-194
Authors:
Hakak, Y
Walker, JR
Li, C
Wong, WH
Davis, KL
Buxbaum, JD
Haroutunian, V
Fienberg, AA
Citation: Y. Hakak et al., Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia, P NAS US, 98(8), 2001, pp. 4746-4751
Authors:
Dracheva, S
Haroutunian, V
Citation: S. Dracheva et V. Haroutunian, Locomotor behavior of dopamine D1 receptor transgenic/D2 receptor deficient hybrid mice, BRAIN RES, 905(1-2), 2001, pp. 142-151
Authors:
Ho, L
Purohit, D
Haroutunian, V
Luterman, JD
Willis, F
Naslund, J
Buxbaum, JD
Mohs, RC
Aisen, PS
Pasinetti, GM
Citation: L. Ho et al., Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease, ARCH NEUROL, 58(3), 2001, pp. 487-492
Authors:
Smith, RE
Haroutunian, V
Davis, KL
Meador-Woodruff, JH
Citation: Re. Smith et al., Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia, AM J PSYCHI, 158(9), 2001, pp. 1393-1399
Authors:
Dracheva, S
Marras, SAE
Elhakem, SL
Kramer, FR
Davis, KL
Haroutunian, V
Citation: S. Dracheva et al., N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia, AM J PSYCHI, 158(9), 2001, pp. 1400-1410
Authors:
Parvathy, S
Naslund, J
Haroutunian, V
Buxbaum, JD
Citation: S. Parvathy et al., Levels of total and deposited A beta are correlated with dementia, ALZHEIMER'S DISEASE, 2001, pp. 311-317
Authors:
Harvey, PD
Jacobsen, H
Mancini, D
Parrella, M
White, L
Haroutunian, V
Davis, KL
Citation: Pd. Harvey et al., Clinical, cognitive and functional characteristics of long-stay patients with schizophrenia: a comparison of VA and state hospital patients, SCHIZOPHR R, 43(1), 2000, pp. 3-9
Authors:
Gluck, MR
Jayatilleke, E
Shaw, S
Rowan, AJ
Haroutunian, V
Citation: Mr. Gluck et al., CNS oxidative stress associated with the kainic acid rodent model of experimental epilepsy, EPILEPSY R, 39(1), 2000, pp. 63-71
Authors:
Gibson, GE
Haroutunian, V
Zhang, H
Park, LCH
Shi, Q
Lesser, M
Mohs, RC
Sheu, RKF
Blass, JP
Citation: Ge. Gibson et al., Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype, ANN NEUROL, 48(3), 2000, pp. 297-303
Authors:
Naslund, J
Haroutunian, V
Mohs, R
Davis, KL
Davies, P
Greengard, P
Buxbaum, JD
Citation: J. Naslund et al., Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline, J AM MED A, 283(12), 2000, pp. 1571-1577
Authors:
Perry, E
Martin-Ruiz, C
Lee, M
Griffiths, M
Johnson, M
Piggott, M
Haroutunian, V
Buxbaum, JD
Nasland, J
Davis, K
Gotti, C
Clementi, F
Tzartos, S
Cohen, O
Soreq, H
Jaros, E
Perry, R
Ballard, C
McKeith, I
Court, J
Citation: E. Perry et al., Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy bodydiseases, EUR J PHARM, 393(1-3), 2000, pp. 215-222
Authors:
Sokolov, BP
Tcherepanov, AA
Haroutunian, V
Davis, KL
Citation: Bp. Sokolov et al., Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients, BIOL PSYCHI, 48(3), 2000, pp. 184-196
Authors:
Richardson-Burns, SM
Haroutunian, V
Davis, KL
Watson, SJ
Meador-Woodruff, JH
Citation: Sm. Richardson-burns et al., Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus, BIOL PSYCHI, 47(1), 2000, pp. 22-28
Authors:
Haroutunian, V
Serby, M
Purohit, DP
Perl, DP
Marin, D
Lantz, M
Mohs, RC
Davis, KL
Citation: V. Haroutunian et al., Contribution of lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions, ARCH NEUROL, 57(8), 2000, pp. 1145-1150
Authors:
Luterman, JD
Haroutunian, V
Yemul, S
Purohit, D
Aisen, PS
Mohs, R
Pasinetti, GM
Citation: Jd. Luterman et al., Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia, ARCH NEUROL, 57(8), 2000, pp. 1153-1160
Authors:
Ibrahim, HM
Hogg, AJ
Healy, DJ
Haroutunian, V
Davis, KL
Meador-Woodruff, JH
Citation: Hm. Ibrahim et al., Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia, AM J PSYCHI, 157(11), 2000, pp. 1811-1823
Authors:
Gouras, GK
Tsai, J
Naslund, J
Vincent, B
Edgar, M
Checler, F
Greenfield, JP
Haroutunian, V
Buxbaum, JD
Xu, HX
Greengard, P
Relkin, NR
Citation: Gk. Gouras et al., Intraneuronal A beta 42 accumulation in human brain, AM J PATH, 156(1), 2000, pp. 15-20
Authors:
Sheu, KFR
Brown, AM
Haroutunian, V
Kristal, BS
Thaler, H
Lesser, M
Kalaria, RN
Relkin, NR
Mohs, RC
Lilius, L
Lannfelt, L
Blass, JP
Citation: Kfr. Sheu et al., Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population, ANN NEUROL, 45(1), 1999, pp. 48-53
Authors:
Davis, KL
Marin, D
Purohit, DP
Perl, D
Lantz, M
Austin, G
Haroutunian, V
Citation: Kl. Davis et al., Cholinergic markers in Alzheimer disease - Reply, J AM MED A, 282(23), 1999, pp. 2208-2209
Authors:
Davis, KL
Mohs, RC
Marin, D
Purohit, DP
Perl, DP
Lantz, M
Austin, G
Haroutunian, V
Citation: Kl. Davis et al., Cholinergic markers in elderly patients with early signs of Alzheimer disease, J AM MED A, 281(15), 1999, pp. 1401-1406